ZA200210402B - Methods and composition for oral vaccination. - Google Patents
Methods and composition for oral vaccination. Download PDFInfo
- Publication number
- ZA200210402B ZA200210402B ZA200210402A ZA200210402A ZA200210402B ZA 200210402 B ZA200210402 B ZA 200210402B ZA 200210402 A ZA200210402 A ZA 200210402A ZA 200210402 A ZA200210402 A ZA 200210402A ZA 200210402 B ZA200210402 B ZA 200210402B
- Authority
- ZA
- South Africa
- Prior art keywords
- virus
- vaccine
- canine
- animal
- clostridium
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims description 48
- 238000000034 method Methods 0.000 title claims description 38
- 238000002255 vaccination Methods 0.000 title description 21
- 229960005486 vaccine Drugs 0.000 claims description 104
- 241001465754 Metazoa Species 0.000 claims description 83
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 46
- 239000000427 antigen Substances 0.000 claims description 42
- 108091007433 antigens Proteins 0.000 claims description 42
- 102000036639 antigens Human genes 0.000 claims description 42
- 238000009472 formulation Methods 0.000 claims description 36
- 239000000796 flavoring agent Substances 0.000 claims description 29
- 239000003651 drinking water Substances 0.000 claims description 26
- 235000020188 drinking water Nutrition 0.000 claims description 26
- 235000019634 flavors Nutrition 0.000 claims description 26
- 241000282465 Canis Species 0.000 claims description 21
- 241000193403 Clostridium Species 0.000 claims description 21
- 241000700605 Viruses Species 0.000 claims description 20
- 241000282898 Sus scrofa Species 0.000 claims description 18
- 201000010099 disease Diseases 0.000 claims description 18
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 18
- 235000020357 syrup Nutrition 0.000 claims description 17
- 239000006188 syrup Substances 0.000 claims description 17
- 241000283690 Bos taurus Species 0.000 claims description 15
- 241000283073 Equus caballus Species 0.000 claims description 14
- 241000186810 Erysipelothrix rhusiopathiae Species 0.000 claims description 14
- 208000015181 infectious disease Diseases 0.000 claims description 13
- 244000144977 poultry Species 0.000 claims description 13
- 241000894006 Bacteria Species 0.000 claims description 12
- 241000589902 Leptospira Species 0.000 claims description 12
- 241000282326 Felis catus Species 0.000 claims description 11
- 239000003795 chemical substances by application Substances 0.000 claims description 10
- 230000008569 process Effects 0.000 claims description 10
- 241000282472 Canis lupus familiaris Species 0.000 claims description 9
- 241000282324 Felis Species 0.000 claims description 9
- 230000002458 infectious effect Effects 0.000 claims description 8
- 241000283707 Capra Species 0.000 claims description 7
- 241001494479 Pecora Species 0.000 claims description 7
- 241000588779 Bordetella bronchiseptica Species 0.000 claims description 6
- 208000002606 Paramyxoviridae Infections Diseases 0.000 claims description 6
- 206010037742 Rabies Diseases 0.000 claims description 6
- 241000712461 unidentified influenza virus Species 0.000 claims description 6
- 241001550390 Leptospira interrogans serovar Canicola Species 0.000 claims description 5
- 241000589926 Leptospira interrogans serovar Hardjo Species 0.000 claims description 5
- 241001518154 Leptospira kirschneri serovar Grippotyphosa Species 0.000 claims description 5
- 241000125945 Protoparvovirus Species 0.000 claims description 5
- 241000702670 Rotavirus Species 0.000 claims description 5
- 241000607142 Salmonella Species 0.000 claims description 4
- 230000001939 inductive effect Effects 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 241000606750 Actinobacillus Species 0.000 claims description 3
- 241000711404 Avian avulavirus 1 Species 0.000 claims description 3
- 241000711443 Bovine coronavirus Species 0.000 claims description 3
- 241000702673 Bovine rotavirus Species 0.000 claims description 3
- 208000027312 Bursal disease Diseases 0.000 claims description 3
- 241000711506 Canine coronavirus Species 0.000 claims description 3
- 241001647378 Chlamydia psittaci Species 0.000 claims description 3
- 241001533384 Circovirus Species 0.000 claims description 3
- 241001656807 Clostridium haemolyticum Species 0.000 claims description 3
- 206010012735 Diarrhoea Diseases 0.000 claims description 3
- 208000000655 Distemper Diseases 0.000 claims description 3
- 241000605312 Ehrlichia canis Species 0.000 claims description 3
- 241000588724 Escherichia coli Species 0.000 claims description 3
- 241001646719 Escherichia coli O157:H7 Species 0.000 claims description 3
- 208000002613 Feline Panleukopenia Diseases 0.000 claims description 3
- 241000713800 Feline immunodeficiency virus Species 0.000 claims description 3
- 241000711475 Feline infectious peritonitis virus Species 0.000 claims description 3
- 241000714165 Feline leukemia virus Species 0.000 claims description 3
- 241000701047 Gallid alphaherpesvirus 2 Species 0.000 claims description 3
- 208000005577 Gastroenteritis Diseases 0.000 claims description 3
- 241000224467 Giardia intestinalis Species 0.000 claims description 3
- 241000204031 Mycoplasma Species 0.000 claims description 3
- 208000005342 Porcine Reproductive and Respiratory Syndrome Diseases 0.000 claims description 3
- 241000711493 Porcine respiratory coronavirus Species 0.000 claims description 3
- 241000702263 Reovirus sp. Species 0.000 claims description 3
- 241000725643 Respiratory syncytial virus Species 0.000 claims description 3
- 206010051497 Rhinotracheitis Diseases 0.000 claims description 3
- 241000392514 Salmonella enterica subsp. enterica serovar Dublin Species 0.000 claims description 3
- 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 claims description 3
- 241000194048 Streptococcus equi Species 0.000 claims description 3
- 206010043376 Tetanus Diseases 0.000 claims description 3
- 208000005466 Western Equine Encephalomyelitis Diseases 0.000 claims description 3
- 201000005806 Western equine encephalitis Diseases 0.000 claims description 3
- 206010006451 bronchitis Diseases 0.000 claims description 3
- 208000014058 canine distemper Diseases 0.000 claims description 3
- 229940051998 ehrlichia canis Drugs 0.000 claims description 3
- 229940085435 giardia lamblia Drugs 0.000 claims description 3
- 208000009305 pseudorabies Diseases 0.000 claims description 3
- 241000009328 Perro Species 0.000 claims 3
- 241000701157 Canine mastadenovirus A Species 0.000 claims 2
- 208000006825 Eastern Equine Encephalomyelitis Diseases 0.000 claims 2
- 201000005804 Eastern equine encephalitis Diseases 0.000 claims 2
- 208000002687 Venezuelan Equine Encephalomyelitis Diseases 0.000 claims 2
- 241000193466 Clostridium septicum Species 0.000 claims 1
- 238000011260 co-administration Methods 0.000 claims 1
- 241000282887 Suidae Species 0.000 description 28
- 230000003612 virological effect Effects 0.000 description 17
- 230000001580 bacterial effect Effects 0.000 description 14
- 229940126578 oral vaccine Drugs 0.000 description 12
- 235000013594 poultry meat Nutrition 0.000 description 9
- 241000271566 Aves Species 0.000 description 8
- 235000013372 meat Nutrition 0.000 description 6
- 201000000297 Erysipelas Diseases 0.000 description 5
- 210000002445 nipple Anatomy 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 241000283086 Equidae Species 0.000 description 4
- 244000144993 groups of animals Species 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 238000002347 injection Methods 0.000 description 4
- 239000007924 injection Substances 0.000 description 4
- 241000287828 Gallus gallus Species 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 235000013330 chicken meat Nutrition 0.000 description 3
- 239000011859 microparticle Substances 0.000 description 3
- 230000035899 viability Effects 0.000 description 3
- 208000035473 Communicable disease Diseases 0.000 description 2
- 238000011887 Necropsy Methods 0.000 description 2
- 208000010359 Newcastle Disease Diseases 0.000 description 2
- 230000002238 attenuated effect Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 238000012217 deletion Methods 0.000 description 2
- 230000037430 deletion Effects 0.000 description 2
- 230000006806 disease prevention Effects 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 201000002491 encephalomyelitis Diseases 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 244000144980 herd Species 0.000 description 2
- 230000000415 inactivating effect Effects 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 238000010255 intramuscular injection Methods 0.000 description 2
- 239000007927 intramuscular injection Substances 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 231100000636 lethal dose Toxicity 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000000405 serological effect Effects 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 238000010561 standard procedure Methods 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 241000272517 Anseriformes Species 0.000 description 1
- 231100000699 Bacterial toxin Toxicity 0.000 description 1
- 241000167854 Bourreria succulenta Species 0.000 description 1
- 241000701931 Canine parvovirus Species 0.000 description 1
- 244000241235 Citrullus lanatus Species 0.000 description 1
- 235000012828 Citrullus lanatus var citroides Nutrition 0.000 description 1
- 241000193449 Clostridium tetani Species 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 241000702680 Equine rotavirus Species 0.000 description 1
- 235000016623 Fragaria vesca Nutrition 0.000 description 1
- 240000009088 Fragaria x ananassa Species 0.000 description 1
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 1
- 206010064571 Gene mutation Diseases 0.000 description 1
- 206010024264 Lethargy Diseases 0.000 description 1
- 241000220225 Malus Species 0.000 description 1
- 235000011430 Malus pumila Nutrition 0.000 description 1
- 235000015103 Malus silvestris Nutrition 0.000 description 1
- 241000286209 Phasianidae Species 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- 206010039101 Rhinorrhoea Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 206010042434 Sudden death Diseases 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 229940025131 amylases Drugs 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 239000000688 bacterial toxin Substances 0.000 description 1
- 239000001045 blue dye Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 235000019693 cherries Nutrition 0.000 description 1
- RNFNDJAIBTYOQL-UHFFFAOYSA-N chloral hydrate Chemical compound OC(O)C(Cl)(Cl)Cl RNFNDJAIBTYOQL-UHFFFAOYSA-N 0.000 description 1
- 229960002327 chloral hydrate Drugs 0.000 description 1
- 230000001332 colony forming effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000000120 cytopathologic effect Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000001687 destabilization Effects 0.000 description 1
- 230000003292 diminished effect Effects 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000013401 experimental design Methods 0.000 description 1
- 244000144992 flock Species 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000008369 fruit flavor Substances 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 238000010166 immunofluorescence Methods 0.000 description 1
- 230000002163 immunogen Effects 0.000 description 1
- 230000005847 immunogenicity Effects 0.000 description 1
- 239000012678 infectious agent Substances 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000008774 maternal effect Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 238000007431 microscopic evaluation Methods 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 208000010753 nasal discharge Diseases 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 206010040882 skin lesion Diseases 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000002798 spectrophotometry method Methods 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 241000701161 unidentified adenovirus Species 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Fodder In General (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US21535900P | 2000-06-30 | 2000-06-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200210402B true ZA200210402B (en) | 2004-03-23 |
Family
ID=22802674
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200210402A ZA200210402B (en) | 2000-06-30 | 2002-12-20 | Methods and composition for oral vaccination. |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US20020025325A1 (de) |
| EP (1) | EP1294399A2 (de) |
| JP (1) | JP2004501979A (de) |
| KR (1) | KR20030013480A (de) |
| CN (1) | CN100457179C (de) |
| AR (1) | AR030702A1 (de) |
| AU (2) | AU2001270135B2 (de) |
| BG (1) | BG107282A (de) |
| BR (1) | BR0111916A (de) |
| CZ (1) | CZ20024222A3 (de) |
| HU (1) | HUP0301394A3 (de) |
| MX (1) | MXPA02012201A (de) |
| MY (1) | MY128159A (de) |
| NZ (1) | NZ523329A (de) |
| PL (1) | PL360026A1 (de) |
| WO (1) | WO2002002139A2 (de) |
| YU (1) | YU99102A (de) |
| ZA (1) | ZA200210402B (de) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7923023B2 (en) * | 2002-02-25 | 2011-04-12 | Astech International LLC | Method and composition for delivery of medicants to animals |
| US8519008B2 (en) | 2003-01-22 | 2013-08-27 | Purina Animal Nutrition Llc | Method and composition for improving the health of young monogastric mammals |
| US8637047B2 (en) * | 2003-10-30 | 2014-01-28 | Boehringer Ingelheim Vetmedica, Inc. | Erysipelothrix rhusiopathiae-haemophilus parasuis vaccine and methods of using the same |
| US20050158367A1 (en) * | 2004-01-16 | 2005-07-21 | The Procter & Gamble Company | Liquid compositions comprising one or more medicaments |
| US8834891B2 (en) * | 2005-03-14 | 2014-09-16 | Boehringer Ingelheim Vetmedica, Inc. | Immunogenic compositions comprising Lawsonia intracellularis |
| US11865172B2 (en) | 2005-04-21 | 2024-01-09 | University Of Florida Research Foundation, Inc. | Materials and methods for respiratory disease control in canines |
| US7959929B2 (en) * | 2005-04-21 | 2011-06-14 | University Of Florida Research Foundation, Inc. | Materials and methods for respiratory disease control in canines |
| US8398994B2 (en) * | 2005-07-15 | 2013-03-19 | Boehringer Ingelheim Vetmedica, Inc. | Lawsonia vaccine and methods of use thereof |
| WO2007047728A2 (en) * | 2005-10-20 | 2007-04-26 | Wyeth | Compositions and methods for the treatment of canine influenza virus disease |
| US8052971B2 (en) * | 2005-11-21 | 2011-11-08 | MG Biologics | Oral use of specific antibodies for intestinal health |
| US7682619B2 (en) | 2006-04-06 | 2010-03-23 | Cornell Research Foundation, Inc. | Canine influenza virus |
| US8470336B2 (en) * | 2006-05-25 | 2013-06-25 | Boehringer Ingelheim Vetmedica, Inc. | Vaccination of young animals against Lawsonia intracellularis infections |
| JPWO2008032796A1 (ja) | 2006-09-13 | 2010-01-28 | 日本全薬工業株式会社 | 新規イヌ用ワクチン |
| CA2667454C (en) * | 2006-10-25 | 2015-12-01 | Intervet International B.V. | Feline influenza vaccine and method of use |
| US20100028379A1 (en) | 2006-12-27 | 2010-02-04 | Pfizer, Inc | Methods of vaccine administration |
| US8398970B2 (en) * | 2007-09-17 | 2013-03-19 | Boehringer Ingelheim Vetmedica, Inc. | Method of preventing early Lawsonia intracellularis infections |
| JP5257939B2 (ja) * | 2009-02-24 | 2013-08-07 | 独立行政法人農業・食品産業技術総合研究機構 | 豚丹毒・豚マイコプラズマ肺炎経口投与型多価ワクチン |
| EP2453916A4 (de) * | 2009-07-17 | 2013-06-05 | Univ Oklahoma State | Supralinguale impfstoffe und applikatoren |
| US8453601B2 (en) * | 2011-05-19 | 2013-06-04 | C-Lock Inc. | Vaccine and health-related applications for ruminant breath monitoring system |
| US20140127352A1 (en) * | 2012-11-05 | 2014-05-08 | Nestec Sa | Flavored drinking waters and methods for improving hydration for animals |
| CA2905375A1 (en) | 2013-03-15 | 2014-09-18 | Camas Incorporated | Methods and compositions for reducing microorganisms in the oropharynx, nasopharynx and oral cavities |
| AU2016255437B2 (en) | 2015-04-28 | 2020-10-08 | Mars, Incorporated | Process of preparing a sterilized wet pet food product |
| WO2018099889A1 (en) * | 2016-11-29 | 2018-06-07 | Intervet International B.V. | Swine vaccine |
| NL2018155B1 (en) * | 2017-01-11 | 2018-07-25 | Intervet Int Bv | Oral vaccine against ruminant respiratory disease |
| EP3554254A1 (de) | 2016-12-15 | 2019-10-23 | Société des Produits Nestlé S.A. | Zusammensetzungen und verfahren zur modulierung von bakterien bei einer haustier |
| WO2020142778A1 (en) * | 2019-01-04 | 2020-07-09 | Boehringer Ingelheim Animal Health USA Inc. | Attenuated bordetella bronchiseptica strains, oral vaccines containing the attenuated strains, and methods of making & use thereof |
| KR102234525B1 (ko) * | 2020-08-28 | 2021-03-30 | 안병철 | 송아지의 점막관련 전염성 질병을 예방 또는 치료하기 위한 혈청의 제조방법, 상기 방법에 의해 제조된 혈청 및 이의 용도 |
| US10973908B1 (en) | 2020-05-14 | 2021-04-13 | David Gordon Bermudes | Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine |
| CN115040468B (zh) * | 2022-05-16 | 2023-02-07 | 中国农业科学院北京畜牧兽医研究所 | 一种中大体型动物口服免疫或给药“辣条”及其生产方法 |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2966443A (en) * | 1959-06-22 | 1960-12-27 | American Cyanamid Co | Trivalent poliomyelitis live virus vaccine |
| US3224941A (en) * | 1963-01-21 | 1965-12-21 | Lilly Co Eli | Resin compositions and method for controlling diarrhea |
| GB1102676A (en) * | 1965-10-08 | 1968-02-07 | Hart Mfg Co H W | Apparatus for supplying water to fowls |
| DE1792256C3 (de) * | 1968-08-10 | 1979-07-05 | Kali-Chemie Pharma Gmbh, 3000 Hannover | Oral applizierbare, polyvalente Impfstoffe gegen lokale Darminfektionen |
| US4141229A (en) * | 1977-10-11 | 1979-02-27 | Stanly Knitting Mills, Inc. | Knit cap with elastic head band |
| US5882649A (en) * | 1990-04-24 | 1999-03-16 | Flustat Pty. Ltd. | Oral vaccine comprising antigen surface-associated with red blood cells |
| ES2136064T3 (es) * | 1990-06-13 | 1999-11-16 | Pfizer | Vacunas de toxoide de pasteurella multocida. |
| US5846805A (en) * | 1991-08-26 | 1998-12-08 | Boehringer Ingelheim Animal Health, Inc. | Culture of swine infertility and respiratory syndrome virus in simian cells |
| US5419907A (en) * | 1992-11-10 | 1995-05-30 | Iowa State University Research Foundation, Inc. | Pathogenic porcine respiratory coronavirus |
| KR100304064B1 (ko) * | 1993-08-12 | 2001-11-22 | 다카하시 미치나오 | 구강용조성물 |
| FR2710500B1 (fr) * | 1993-09-27 | 1995-12-01 | Virbac Laboratoires | Composition et système à administration orale pour animaux, leur procédé de préparation et leurs applications. |
| US6019982A (en) * | 1994-08-26 | 2000-02-01 | The Administrators Of The Tulane Educational Fund | Mutant enterotoxin effective as a non-toxic oral adjuvant |
| US5985336A (en) * | 1995-06-07 | 1999-11-16 | Novus International, Inc. | Nutrient formulation and process for feeding young poultry and other animals |
| US5884583A (en) * | 1997-03-28 | 1999-03-23 | Rhone Merieux, Inc. | Field bag boost vaccination delivery system |
| US6100388A (en) * | 1998-03-16 | 2000-08-08 | Biogaia Biologies Ab | Lactobacilli harboring aggregation gene as a vaccine delivery vehicle |
| US20020064517A1 (en) * | 1998-04-30 | 2002-05-30 | Stewart A. Cederholm-Williams | Fibrin sealant as a transfection/transformation vehicle for gene therapy |
| WO1999059626A1 (en) * | 1998-05-15 | 1999-11-25 | Mkb Investments Limited Partnership | Compositions and method for immunizing poultry |
| US6713073B1 (en) * | 1998-07-24 | 2004-03-30 | Megan Health, Inc. | Method of vaccination of newly hatched poultry |
| US6399074B1 (en) * | 1998-07-24 | 2002-06-04 | Megan Health, Inc. | Live attenuated salmonella vaccines to control avian pathogens |
| US6552024B1 (en) * | 1999-01-21 | 2003-04-22 | Lavipharm Laboratories Inc. | Compositions and methods for mucosal delivery |
| KR100324441B1 (ko) * | 1999-02-08 | 2002-02-27 | 이은선 | 위염, 위궤양, 십이지장궤양 예방을 위한 식품 |
| US6225304B1 (en) * | 1999-02-17 | 2001-05-01 | Pharmaceutical Solutions, Inc. | Soluble forms of amoxicillin and treatment of animals |
| US7018638B2 (en) * | 2000-12-19 | 2006-03-28 | Wyeth | Mycoplasma hyopneumoniae bacterin vaccine |
-
2001
- 2001-06-14 MY MYPI20012800A patent/MY128159A/en unknown
- 2001-06-19 AR ARP010102904A patent/AR030702A1/es unknown
- 2001-06-21 US US09/887,296 patent/US20020025325A1/en not_active Abandoned
- 2001-06-22 WO PCT/US2001/020155 patent/WO2002002139A2/en active IP Right Grant
- 2001-06-22 YU YU99102A patent/YU99102A/sh unknown
- 2001-06-22 CZ CZ20024222A patent/CZ20024222A3/cs unknown
- 2001-06-22 PL PL36002601A patent/PL360026A1/xx not_active Application Discontinuation
- 2001-06-22 MX MXPA02012201A patent/MXPA02012201A/es not_active Application Discontinuation
- 2001-06-22 NZ NZ523329A patent/NZ523329A/en unknown
- 2001-06-22 CN CNB018121500A patent/CN100457179C/zh not_active Expired - Fee Related
- 2001-06-22 EP EP01948685A patent/EP1294399A2/de not_active Withdrawn
- 2001-06-22 AU AU2001270135A patent/AU2001270135B2/en not_active Ceased
- 2001-06-22 KR KR1020027018051A patent/KR20030013480A/ko not_active Application Discontinuation
- 2001-06-22 AU AU7013501A patent/AU7013501A/xx active Pending
- 2001-06-22 HU HU0301394A patent/HUP0301394A3/hu unknown
- 2001-06-22 BR BR0111916-8A patent/BR0111916A/pt not_active IP Right Cessation
- 2001-06-22 JP JP2002506760A patent/JP2004501979A/ja active Pending
-
2002
- 2002-11-18 BG BG107282A patent/BG107282A/bg unknown
- 2002-12-20 ZA ZA200210402A patent/ZA200210402B/en unknown
-
2005
- 2005-12-29 US US11/321,389 patent/US20060171960A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| HUP0301394A2 (hu) | 2003-08-28 |
| US20020025325A1 (en) | 2002-02-28 |
| BG107282A (bg) | 2003-06-30 |
| AU2001270135B2 (en) | 2005-05-26 |
| CN1529615A (zh) | 2004-09-15 |
| EP1294399A2 (de) | 2003-03-26 |
| HUP0301394A3 (en) | 2004-10-28 |
| MY128159A (en) | 2007-01-31 |
| BR0111916A (pt) | 2003-05-13 |
| KR20030013480A (ko) | 2003-02-14 |
| PL360026A1 (en) | 2004-09-06 |
| NZ523329A (en) | 2005-10-28 |
| CN100457179C (zh) | 2009-02-04 |
| AR030702A1 (es) | 2003-09-03 |
| MXPA02012201A (es) | 2003-06-06 |
| YU99102A (sh) | 2006-01-16 |
| JP2004501979A (ja) | 2004-01-22 |
| AU7013501A (en) | 2002-01-14 |
| US20060171960A1 (en) | 2006-08-03 |
| CZ20024222A3 (cs) | 2003-06-18 |
| WO2002002139A3 (en) | 2002-07-04 |
| WO2002002139A2 (en) | 2002-01-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2001270135B2 (en) | Methods and composition for oral vaccination | |
| AU2001270135A1 (en) | Methods and composition for oral vaccination | |
| Baskerville et al. | Aujeszky's disease in pigs. | |
| CA2769223C (en) | Sticky soft gel for treating poultry | |
| US20130064852A1 (en) | Vaccine against mycoplasma, hyopneumoniae, suitable for administration in the presence of maternally derived antibodies | |
| Bey et al. | Formulation of vaccines | |
| Makoschey | Modes of vaccine administration at a glance | |
| Wilson et al. | Mucosal vaccine development for veterinary and aquatic diseases | |
| US11185579B2 (en) | Oral vaccine against ruminant respiratory disease comprising polyvinylpyrrolidone | |
| US20110014237A1 (en) | Vaccine for Protection Against Haemophilus Parasuis Serotype 4 in Piglets | |
| Nimmanapalli et al. | Vaccines the tugboat for prevention-based animal production | |
| AU2005203441A1 (en) | Methods and composition for oral vaccination | |
| HRP20030062A2 (en) | Methods and composition for oral vaccination | |
| Bowersock | Evolving importance of biologics and novel delivery systems in the face of microbial resistance | |
| US20220184198A1 (en) | Composition for mucosal administration to avians | |
| ES2371395T3 (es) | Inhibidor de adherencia de inmunógenos y procedimiento de preparación y uso del mismo. | |
| SIMONSON et al. | RUSSELL BEY | |
| CA3231048A1 (en) | Immunogenic gel compositions | |
| US6517844B1 (en) | Compositions and method for immunizing polutry | |
| AU4078699A (en) | Compositions and method for immunizing poultry | |
| NZ795066A (en) | Oral vaccine against ruminant respiratory disease comprising polyvinylpyrrolidone | |
| Doyle | Can swine erysipelas be eradicated? Epidemiological and immunological aspects. |